FDA punts on how to regulate CBD; burning questions about ChatGPT in health care

The FDA is giving up on trying to figure out a way to regulate CBD on its own, and formally calling on Congress for help.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

January 26, 2023 Check out STAT+

Sponsored By

Adobe STAT+ | The unexpected alliance lobbying for Medicare to pay for new obesity drugs Lawmakers banned coverage of obesity drugs when the Medicare's prescription drug benefit was created in 2003. By Rachel Cohrs After nearly 4 years of deliberation, FDA punts on how to regulate CBD The FDA is giving up on trying to figure out a way to regulate CBD on its own, and formally calling on Congress for help. By Nicholas Florko STAT+ | ChatGPT in health care: 5 burning questions about the buzzy new tool How could ChatGPT be deployed in health and science? Here's STAT's guide to the new technology's potential and risks. By Brittany Trang JOEL SAGET/AFP via Getty Images Live blog: Tracking the meeting of the FDA advisory panel on Covid vaccines At the start of year four of the pandemic — year three of the Covid vaccination program — the FDA is trying to chart a future path. By Helen Branswell and Matthew Herper FDA pulls Evusheld authorization as coronavirus evolution quashes another therapy Evusheld is the latest Covid antibody therapy to be rendered ineffective by the mutations the coronavirus has picked up. By Andrew Joseph HHS' Becerra on enrolling in Medicare, annual Covid vaccines, and seniors' mental health HHS Secretary Xavier Becerra sat down with STAT on his 65th birthday to talk about enrolling in Medicare and annual Covid vaccines. By Sarah Owermohle Mallory Brangan for STAT Watch: How do the new obesity drugs work? Drugs like Wegovy and Ozempic are growing in popularity as obesity medications. This STAT explainer video shows how they work in the body. By Alex Hogan and Mallory Brangan Listen: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection George Scangos, the CEO of Vir Biotechnology, joins us to discuss his retirement and offer some perspective from a 40-year career in biotech. By Adam Feuerstein and Meg Tirrell Opinion: A dangerous loophole for drug ads needs to be closed A loophole in prescription drug regulation exposes American consumers to false and misleading drug ads from on-line businesses. By Thomas J. Moore and G. Caleb Alexander

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser